Symptom Management and Survivorship Plus Coaching for Advanced Cancer Survivors and Their Caregivers
This study is looking at ways to help people with advanced cancer (metastatic or stage IV breast, gastrointestinal, or melanoma cancer) and their caregivers manage symptoms and improve their quality of life. You would receive a "Symptom Management and Survivorship Handbook" (SMSH) which has information on managing 24 common cancer symptoms like fatigue, depression, and pain. Some participants will also receive weekly phone calls from a coach to help them set goals and manage their symptoms. The study aims to see how much these interventions can reduce the severity of your symptoms over 10 weeks. They plan to enroll 200 participants. The current status of the study is unclear.
- Study design
- This is an interventional study planning to enroll 200 participants. It compares receiving a handbook alone versus receiving the handbook plus coaching.
- What's involved
- You would participate in a 10-week program. If in the coaching group, you and your caregiver would receive separate weekly phone calls from a coach.
- Compensation
- Not stated in the trial record.
- Follow-up
- Symptom severity will be measured at 10 weeks.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Symptom Management and Survivorship Plus Coaching for Advanced Cancer Survivors and Their Caregivers
At a glance
Conditions
Where it's being run
1 sites across 1 statesStudy leadership
- Terry A Badger, RN, PhD · PRINCIPAL_INVESTIGATOR · University of Arizona College of Nursing
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Symptom severity10 weeks
Assess whether SMSH combined with health coaching reduces the burden of 24 symptoms over 10 weeks compared to SMSH alone. Symptom burden will be measured using summary severity and interference scores from the Patient-Reported Outcome Common Terminology Criteria for Adverse Events (PRO-CTCAE). Severity is rated on a scale of 0=none, 1=mild, 2=moderate, 3=severe, 4=very severe. Interference is rated on a scale of 0=not at all, 1=a little bit, 2=somewhat, 3=quite a bit, 4=very much. Frequency is rated as 0=never, 1=rarely, 2=occasionally, 3=frequently, 4=almost constantly. As outlined in the PRO-CTCAE, frequency, severity, and interference questions will be asked for each item available. If frequency is "never," severity and interference will not be asked. Summary scores for severity and interference will be derived from the toxicity index (TI) developed by Rogatko et al. for CTCAE grades and applied to the PRO-CTCAE scores over weeks 1-8. Higher scores indicate worse outcomes.